Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic potential of cannabinoids in schizophrenia.
Kucerova J, Tabiova K, Drago F, Micale V. Kucerova J, et al. Among authors: drago f. Recent Pat CNS Drug Discov. 2014 Apr;9(1):13-25. doi: 10.2174/1574889809666140307115532. Recent Pat CNS Drug Discov. 2014. PMID: 24605939 Review.
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia.
D'Addario C, Micale V, Di Bartolomeo M, Stark T, Pucci M, Sulcova A, Palazzo M, Babinska Z, Cremaschi L, Drago F, Carlo Altamura A, Maccarrone M, Dell'Osso B. D'Addario C, et al. Among authors: drago f. Schizophr Res. 2017 Oct;188:132-140. doi: 10.1016/j.schres.2017.01.022. Epub 2017 Jan 17. Schizophr Res. 2017. PMID: 28108228
Endocannabinoid system, stress and HPA axis.
Micale V, Drago F. Micale V, et al. Among authors: drago f. Eur J Pharmacol. 2018 Sep 5;834:230-239. doi: 10.1016/j.ejphar.2018.07.039. Epub 2018 Jul 20. Eur J Pharmacol. 2018. PMID: 30036537 Review.
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia.
Stark T, Ruda-Kucerova J, Iannotti FA, D'Addario C, Di Marco R, Pekarik V, Drazanova E, Piscitelli F, Bari M, Babinska Z, Giurdanella G, Di Bartolomeo M, Salomone S, Sulcova A, Maccarrone M, Wotjak CT, Starcuk Z Jr, Drago F, Mechoulam R, Di Marzo V, Micale V. Stark T, et al. Among authors: drago f. Neuropharmacology. 2019 Mar 1;146:212-221. doi: 10.1016/j.neuropharm.2018.11.035. Epub 2018 Nov 26. Neuropharmacology. 2019. PMID: 30496751
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats.
Di Bartolomeo M, Stark T, Maurel OM, Iannotti FA, Kuchar M, Ruda-Kucerova J, Piscitelli F, Laudani S, Pekarik V, Salomone S, Arosio B, Mechoulam R, Maccarrone M, Drago F, Wotjak CT, Di Marzo V, Vismara M, Dell'Osso B, D'Addario C, Micale V. Di Bartolomeo M, et al. Among authors: drago f. Pharmacol Res. 2021 Feb;164:105357. doi: 10.1016/j.phrs.2020.105357. Epub 2020 Dec 4. Pharmacol Res. 2021. PMID: 33285233 Free article.
Endocannabinoids and neurodegenerative diseases.
Micale V, Mazzola C, Drago F. Micale V, et al. Among authors: drago f. Pharmacol Res. 2007 Nov;56(5):382-92. doi: 10.1016/j.phrs.2007.09.008. Epub 2007 Sep 11. Pharmacol Res. 2007. PMID: 17950616 Review.
1,107 results